The next 10, 50, 100 years are a crucial moment for raising the voice of people living with diabetes (PwD).

We need to ensure that the upcoming innovations will answer the real needs of PwD, and improve access to diabetes medicines, supplies, technologies, care and education.

Find out about ongoing research projects and innovations, and listen to the testimonials about hopes for the future:

We thank our strategic partners for their support of IDF Europe priority activities.

Boehringer Ingelheim

Special thanks to Lilly Diabetes and Novo Nordisk for their additional support of the IDF Europe Centenary of Insulin Campaign.

Lilly diabetes
Novo Nordisk